Drawing for KILLER LEGS

USPTO serial 88320296

KILLER LEGS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KILLER LEGS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip Y. Braginsky

Philip Y. Braginsky TARTER KRINSKY & DROGIN LLP1350 BROADWAY, TARTER KRINSKY & DROGIN LNEW YORK, NY 10018United States

Goods and services

ClassDescriptionStatusFirst use
003NON-MEDICATED SKIN CARE PREPARATIONS, NAMELY, HAND LOTIONS, FACE AND BODY LOTIONS, SKIN LOTIONS, BODY CREAM, HAND CREAM, SKIN SOAP, BODY WASH FOR HUMANS, FACIAL CLEANSERS, SKIN CLEANSERS, BODY SCRUBS AND FACIAL SCRUBSACTIVE—
005VITAMINS AND NUTRITIONAL SUPPLEMENTS AND DIETARY AND NUTRITIONAL SUPPLEMENTAL DRINKS IN THE NATURE OF VITAMIN AND MINERAL BEVERAGESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 6, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 5, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 4, 2022EX5GSOU EXTENSION 5 GRANTED—
Feb 4, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 28, 2022EXT5SOU EXTENSION 5 FILED—
Jan 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2021EX4GSOU EXTENSION 4 GRANTED—
Jul 28, 2021EXT4SOU EXTENSION 4 FILED—
Jul 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2021EX3GSOU EXTENSION 3 GRANTED—
Jan 29, 2021EXT3SOU EXTENSION 3 FILED—
Jan 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 31, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2020EX2GSOU EXTENSION 2 GRANTED—
Jul 29, 2020EXT2SOU EXTENSION 2 FILED—
Jul 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 29, 2020EXT1SOU EXTENSION 1 FILED—
Jan 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2019ALIEASSIGNED TO LIE—
Apr 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 1, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Apr 1, 2019CNSLSUSPENSION LETTER WRITTEN—
Apr 1, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 1, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 1, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 1, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 26, 2019DOCKASSIGNED TO EXAMINER—
Mar 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 4, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance